Pharmacokinetic study of SPARC1613 and Reference1613
- Conditions
- Metastatic breast cancer
- Registration Number
- CTRI/2016/12/007565
- Lead Sponsor
- Sun Pharma Advanced Research Company Limited
- Brief Summary
This was a multicenter, open-label, randomized, two-period, two treatment, single dose, crossover
bioequivalence study.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 142
- The subject has given written, informed consent (or legally acceptable representative /impartial witness when applicable) and is available for the duration of study 2.
- Histologically or cytologically confirmed diagnosis of breast cancer 3.
- Estimated life expectancy of at least 12 weeks 4.
- ECOG performance status less than 1.
- Known hypersensitivity to either of the study drugs or their excipients 2.
- Inability to undergo venipuncture and/or tolerate venous access 3.
- Presence of clinically symptomatic active CNS metastases, including leptomeningial involvement, requiring steroid or radiation therapy 4.
- Pre-existing clinically significant peripheral neuropathy.
Study & Design
- Study Type
- BA/BE
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pharmacokinetic parameter Cmax, and AUC Pharmacokinetic parameter Cmax, and AUC
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (24)
Apple Hospital
🇮🇳Surat, GUJARAT, India
Curie Manavata Cancer Centre
🇮🇳Nashik, MAHARASHTRA, India
Dept. of Radiation Therapy and Oncology, Govt. Medical College and Hospital
🇮🇳Nagpur, MAHARASHTRA, India
Dr Rai Memorial Medical Centre
🇮🇳Chennai, TAMIL NADU, India
HCG Multi Speciliaty Ethic Committee
🇮🇳Ahmadabad, GUJARAT, India
Health Care Global Enterprises Ltd.
🇮🇳Bangalore, KARNATAKA, India
Kailash Cancer Hospital & Research Centre
🇮🇳Vadodara, GUJARAT, India
Kasturba Medical College Hospital
🇮🇳Kannada, KARNATAKA, India
KLEs Dr. Prabhakar Kore Hospital & Medical Research Centre
🇮🇳Belgaum, KARNATAKA, India
Lokmanya Tilak Munciple Medical College and General Hospital
🇮🇳Mumbai, MAHARASHTRA, India
Scroll for more (14 remaining)Apple Hospital🇮🇳Surat, GUJARAT, IndiaDr Ghanshyam PatelPrincipal investigator9376913131gnonco@gmail.com